New trends for pain relief in gynaecologic oncology.
In pre-terminal and terminal gynaecological patients with persistent cancer pain, now it is possible to carry out some anthalgic methods associated or not to parenteral administration of non-narcotic or narcotic analgesic, i.e. intrathecal neurolytic injections and epidural narcotic administration. Many favourable results have been obtained by means of single or repeated 7% phenol in glycerine injections to patients with advanced but not terminal cancer affected by somatic and segmental pain or by perineal pain. In order to control more extensive pains, epidural injections of morphine in saline have been employed in preterminal patients. This method appears to be the best answer to many problems complained by the patients: pain, depression, malaise. As a matter of fact, low doses of epidural morphine induce both complete pain relief and sedation or slight drowsiness.
D001340:Autonomic Nerve Block; D002045:Bupivacaine / Q000008:administration & dosage; D002447:Celiac Plexus; D004824:Epidural Space; D005260:Female; D005833:Genital Neoplasms, Female / Q000628:therapy*; D006801:Humans; D007278:Injections, Spinal; D009020:Morphine / Q000008:administration & dosage; D010148:Intractable Pain / Q000628:therapy*; D010166:Palliative Care / Q000639:trends; D010636:Phenols; D013727:Terminal Care / Q000639:trends
D010636:Phenols; D009020:Morphine; D002045:Bupivacaine